Back to Search
SADIQ SHAKIR, M.D.
M.D.
Internal Medicine Physician
NPI: 1699791319Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
14403(OK)
Research & Publications (20)
Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study.
PMID 19459717·Drug Saf·2009
8-other
The mechanism of Bacillus anthracis intracellular germination requires multiple and highly diverse genetic loci.
PMID 18936179·Infect Immun·2009
7-preclinical
Risk management and outcomes of adverse events to pioglitazone in primary care in the UK: an observational study.
PMID 19338380·Drug Saf·2009
8-other
Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England.
PMID 19236123·Drug Saf·2009
8-other
Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
PMID 19419235·Drug Saf·2009
8-other
The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients.
PMID 18990133·BJU Int·2009
4-observational
Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study.
PMID 19132804·Drug Saf·2009
8-other
Prescriber adoption of newly approved selective COX-2 inhibitors.
PMID 18821717·Pharmacoepidemiol Drug Saf·2008
8-other
Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.
PMID 18759508·Drug Saf·2008
8-other
Developing tools for the safety specification in risk management plans: lessons learned from a pilot project.
PMID 18383441·Pharmacoepidemiol Drug Saf·2008
8-other
Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England.
PMID 18366242·Drug Saf·2008
8-other
European commission consultation on pharmacovigilance.
PMID 18058839·Pharmacoepidemiol Drug Saf·2008
8-other
Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.
PMID 18217790·Drug Saf·2008
8-other
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling.
PMID 17508197·Diabetologia·2007
7-preclinical
The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
PMID 18070762·Obesity (Silver Spring)·2007
8-other
Safety of nateglinide as used in general practice in England: results of a prescription-event monitoring study.
PMID 17874223·Acta Diabetol·2007
8-other
A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance.
PMID 17696581·Drug Saf·2007
8-other
The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England.
PMID 17656426·J Psychopharmacol·2007
8-other
Effects of endogenous D-alanine synthesis and autoinhibition of Bacillus anthracis germination on in vitro and in vivo infections.
PMID 17923523·Infect Immun·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1714 S MIDWEST BLVD
MIDWEST CITY, OK 73110 - Phone
- (405) 732-1447
Quick Facts
- NPI
- 1699791319
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile